DTIL SCHEDULE 13G/A: SEC filing

An institutional investor

Filed with the SEC on · accession 0001214659-26-013679

DTIL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 3, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.3% by the first close after the filing.

Summary of the filing

An institutional investor filed an amended Schedule 13G indicating a change in its passive ownership position in Precision Biosciences Inc. The filing does not disclose a specific ownership percentage or share count in the provided text.

Key details

IssuerPrecision Biosciences Inc

How DTIL stock reacted

Close before

$6.95

Nov 2, 2026

First close after

+0.29%

$6.97

5 trading days

—

Since filing

+52.52%

$10.60

✦ Ask GOAX AI about this filing — what it means for DTIL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DTIL?

Click here

Frequently asked questions

What did DTIL file with the SEC on Nov 3, 2026?

DTIL filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G indicating a change in its passive ownership position in Precision Biosciences Inc. The filing does not disclose a specific ownership percentage or share count in the provided text.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did DTIL stock react to this filing?

DTIL closed at $6.95 before the filing and $6.97 on Nov 3, 2026 (+0.29%).

Other DTIL SEC filings

Get alerts when DTIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days